Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome
- PMID: 3771749
- PMCID: PMC268979
- DOI: 10.1128/jcm.24.4.600-606.1986
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome
Abstract
There is no ideal laboratory procedure or culture medium in current use for susceptibility testing of pathogenic yeasts. Six candidate growth media (RPMI 1640 with L-glutamine, yeast nitrogen base, Casamino Acids medium, Mueller-Hinton broth, Sabouraud dextrose broth, and minimum essential medium-Eagle salts) were screened by spectrophotometric absorbance for nucleic acid and protein. From these, two media were selected: a chemically defined growth medium (RPMI 1640 with L-glutamine) and a chemically complex medium (Casamino Acids). MICs of four antifungal agents (5-fluorocytosine, miconazole, ketoconazole, and amphotericin B) for 84 clinical isolates of various Candida species were then determined with both media in agar dilution and microtiter broth dilution systems. The resultant MICs were correlated with clinical outcome for those isolates obtained from patients treated with single antifungal agents, and susceptibility cut points were calculated. Derived MIC cut points for susceptibility were validated in a murine model of systemic candidiasis. RPMI 1640 with L-glutamine was found to have the lowest absorbance values for both nucleic acid and protein, while Casamino Acids medium was highest in both categories. We found that RPMI 1640 with L-glutamine was superior to Casamino Acids medium in the yield of MICs which correlated with actual clinical and animal outcome data. While there were no significant differences in MICs when RPMI 1640 medium was used, the microtiter broth dilution technique was superior to agar dilution in efficiency and ease of performance. We conclude that a microtiter broth system containing RPMI 1640 medium with L-glutamine is a simple, precise, and economical technique for susceptibility testing of pathogenic Candida species. We also suggest that the validation of susceptibility cut points with patient and animal outcome data make this microtiter broth system a preferential method for yeast susceptibility testing.
Similar articles
-
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.J Clin Microbiol. 1986 Oct;24(4):507-11. doi: 10.1128/jcm.24.4.507-511.1986. J Clin Microbiol. 1986. PMID: 3533974 Free PMC article.
-
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.J Clin Microbiol. 1984 Mar;19(3):412-6. doi: 10.1128/jcm.19.3.412-416.1984. J Clin Microbiol. 1984. PMID: 6325491 Free PMC article.
-
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.J Clin Microbiol. 1996 Jul;34(7):1691-3. doi: 10.1128/JCM.34.7.1691-1693.1996. J Clin Microbiol. 1996. PMID: 8784571 Free PMC article.
-
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.J Antimicrob Chemother. 1995 Jun;35(6):739-49. doi: 10.1093/jac/35.6.739. J Antimicrob Chemother. 1995. PMID: 7559186
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
Cited by
-
Effects of temperature on anti-Candida activities of antifungal antibiotics.Antimicrob Agents Chemother. 1993 Apr;37(4):685-91. doi: 10.1128/AAC.37.4.685. Antimicrob Agents Chemother. 1993. PMID: 8494363 Free PMC article.
-
Collaborative investigation of variables in susceptibility testing of yeasts.Antimicrob Agents Chemother. 1990 Sep;34(9):1648-54. doi: 10.1128/AAC.34.9.1648. Antimicrob Agents Chemother. 1990. PMID: 2285276 Free PMC article. Clinical Trial.
-
In vitro and in vivo evaluation of antifungal agents.Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):352-61. doi: 10.1007/BF01963469. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2497014 Review.
-
Chemerin is an antimicrobial agent in human epidermis.PLoS One. 2013;8(3):e58709. doi: 10.1371/journal.pone.0058709. Epub 2013 Mar 20. PLoS One. 2013. PMID: 23527010 Free PMC article.
-
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.J Clin Microbiol. 1992 Nov;30(11):2881-6. doi: 10.1128/jcm.30.11.2881-2886.1992. J Clin Microbiol. 1992. PMID: 1452658 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources